In detail, SNCA overexpression in SK-MEL-28 cells fostered DJ-1 upregulation, while temozolomide treatment concurrently reduced both proteins, suggesting that the interaction and/or protein stability of the α-syn-DJ-1 complex could promote melanoma cell survival and proliferation, representing a possible therapeutic target [66]. The gene discussed is SNCA; the disease is melanoma.